Meteorite logoMeteorite
Back to videos

Video unavailable

This video may be inappropriate for some users.

Cannabis Europa 2022 - The Complexities of Innovation in Cannabis - Michael Sassano, CEO of SOMAÍ

SOMAÍ Pharmaceuticals LTD was present at the Cannabis Europa Conference in London, June 2022. We were proud to be one of the Sponsors of such a significant and impactful event. Our CEO & Founder, Michael Sassano, was one of the featured speakers, discussing with Dean Billington (COO - Brains Bioceutical) and Roby Zomer (CEO - MGC Pharmaceuticals) "The Complexities of Innovation in Cannabis" on the second day of the conference (Wednesday, June 29 2022 11:30 am). Medical Cannabis research continues to move at pace, with new findings helping shape the industry regularly. What are the main obstacles preventing the next phase? Which products can we expect to see on the market next and how will they further benefit patients? Exactly how do you conduct clinical trials for a complex structure such as cannabis? We are joined by a panel of Chief Scientific Officers and regulators, to discuss innovation in the space. ℂ𝕠𝕟𝕟𝕖𝕔𝕥 𝕨𝕚𝕥𝕙 𝕄𝕚𝕔𝕙𝕒𝕖𝕝 𝕊𝕒𝕤𝕤𝕒𝕟𝕠 𝕆𝕟𝕝𝕚𝕟𝕖 » Read Michael’s articles here: https://www.somaipharma.eu/press » Follow Michael on LinkedIn: https://www.linkedin.com/in/michaelsassano3/ » Follow Michael on Facebook: https://m.facebook.com/michael.sassano.37 » Follow Michael on Twitter: https://mobile.twitter.com/Michael_Sassano » Follow Michael on Instagram: https://www.instagram.com/mikesassa/?hl=en ℂ𝕠𝕟𝕟𝕖𝕔𝕥 𝕨𝕚𝕥𝕙 𝕊𝕆𝕄𝔸Í ℙ𝕙𝕒𝕣𝕞𝕒𝕔𝕖𝕦𝕥𝕚𝕔𝕒𝕝𝕤 𝕆𝕟𝕝𝕚𝕟𝕖 » Contact us: https://www.somaipharma.eu/#contact » Get our latest news: https://www.somaipharma.eu/press » Follow SOMAÍ on LinkedIn: https://www.linkedin.com/company/somaipharma/ » Follow SOMAÍ on Facebook: https://www.facebook.com/somaipharma/ » Follow SOMAÍ on Twitter: https://twitter.com/somaipharma » Follow SOMAÍ on Instagram: https://www.instagram.com/somaipharma SOMAÍ Pharmaceuticals LTD is an Ireland-based company that focuses on the cultivation and extraction of cannabis, and producing EU-GMP certified cannabinoid formulations for pharmaceutical distribution. SOMAÍ will be positioned as a top global pharmaceutical distributor of medical-grade, EU-GMP-certified cannabis.

Suggested videos